Alpha Mannosidosis and Mucopolysaccharidoses (MPS) present a broad and heterogeneous clinical spectrum that often challenges timely diagnosis and effective care coordination. The non-specific and overlapping nature of their symptoms with other disorders contributes to diagnostic delays and under-recognition, particularly in healthcare systems lacking dedicated tools or structured pathways.

Given the progressive course and multisystem involvement of these diseases, a coordinated, multidisciplinary approach is essential to ensure early intervention and sustained management. Advances in newborn screening, digital health technologies, and artificial intelligence offer promising avenues to support earlier identification and more accurate patient stratification..

This international educational event brings together experts from diverse specialties to share real-world experiences, discuss evolving therapeutic strategies, and highlight the importance of PROMs in evaluating outcomes and shaping access to care. By fostering clinical collaboration and awareness, the program aims to enhance the quality, continuity, and equity of care for patients affected by rare lysosomal storage disorders..